HOME > Company profile > Subsidiaries

Company Profile

Subsidiaries

¡Nemoto Lumi-Materials Co., Ltd.
Research and Produce Phosphors

¡Nemoto Sensor Engineering Co., Ltd.
Research and Produce Sensors

¡Nemoto Science Co., LTD.
(Head Office) *since March 2010
4-10-9, Takaido-higashi, Suginami-ku, Tokyo 168-0072, Japan
Tel(Main Switchboard) : +81-3-3333-2711
http://www.nemotoscience.co.jp/
Tsukuba Laboratories Map(in Japanese)
6136-4, Ohnogo-machi, Joso-city, Ibaraki-ken 300-2521 Japan
Tel: +81-297-24-1045 Fax: +81-297-24-1047
Sales Group: +81-297-24-0781

Establishment May 2000
Capital 80,000,000(Yen)
Chairman & CEO Ikuyoshi Nemoto
President Hiroki Tomisawa Ph.D.
Director Sakae Komatsu
  Kenji Tsuruhara
  Toshiyuki Mikasa
Auditor Akira Kurabayashi
photo
photo
<Activity of Nemoto Science Co., LTD>
In order to support the development for new drug, Nemoto Science Co., LTD conducts the following studies.

<Research & Screening stage for new drug>
* In vivo and/or in vitro studies for pharmacokinetic screening.
* Custom synthesis using radio isotopes and/or stable isotopes.

<Development stage for new drug>
* Pharmacokinetic studies.
* Toxicokinetic analysis.
* In vitro studies.
* Quantitative analysis and metabolite identification.
* NDA filing, translation, preparation of study reports.


History
1941. Founded for production and sales luminous paints for watches and clocks.
1962. Incorporated as Nemoto & Co., LTD
1984. Tokyo Laboratories of Life Science Div. of Nemoto & Co., LTD opened and started the custom synthesis for radio labeled compounds.
1986. Tsukuba Laboratories of Life Science Div. opened and started contract lab service for pharmacokinetic studies in preclinical area.
1987. Tied up with Chemsyn Science Laboratories in USA, and expanded the custom synthesis of radio labeled compounds.
1992. Tokyo Lab closed, Tsukuba Lab succeeds to activities of Tokyo Lab.
1995. Toxicokinetic analysis under GLP started at Tsukuba Lab.
1997. Pharmacokinetic studies under the Standard for Reliability (Japanese regulations) started at Tsukuba Lab.
2000. Nemoto Science Co., LTD founded, succeeds Life Science Div.
2001. Tied up with RC TRITEC AG in Switzerland, and started the custom synthesis for tritiated compounds.